Entropic Capsule V4: A Targeted Curcumin Delivery Strategy for Beta-Amyloid Plaque Tagging in Alzheimer's Disease

Entropic Capsule V4 presents a bold theoretical design for Alzheimer's intervention—one that doesn't destroy plaques, but teaches the brain to see them. Co-developed by Chris Gabriel and ChatGPT (OpenAI), this glucose-guided capsule delivers curcumin past the blood-brain barrier directly to beta-amyloid plaques. Once there, curcumin alters the plaque surface just enough to reveal its danger, allowing microglia—the brain’s innate immune sentinels—to recognize and clear it. This is not a drug but a signal: a way to awaken forgotten immune instincts without toxicity, antibodies, or overreaction. V4 offers a modular, scalable framework for researchers exploring non-invasive neurodegenerative therapy. It is freely released with no permission required, only attribution.